Left ventricular ejection fraction > % as measured by echocardiogram or multi gated acquisition (MUGA) scan
Left ventricular ejection fraction >= % by transthoracic echocardiography or multi-gated acquisition scan (MUGA) within  days prior to the first dose of the study drug
Left ventricular ejection fraction (LVEF) determined by echocardiogram or multi-gated acquisition scan ? %
Cardiac function: Left ventricular ejection fraction (LVEF) > %; or LV shortening fraction > % by cardiac echocardiogram or by Multi Gated Acquisition Scan (MUGA).
Left ventricular ejection fraction of > % on baseline echocardiography or multi-gated acquisition (MUGA) scan
Normal left ventricular ejection fraction of >= % estimated by multi gated acquisition (MUGA) scan or echocardiogram
Left ventricular ejection fraction >= % on echocardiogram or multi gated acquisition scan (MUGA) scan
Participants must have adequate cardiac function, e.g. left ventricular ejection fraction (LVEF) of > % as assessed by multi-gated acquisition (MUGA) or ultrasound/echocardiography (ECHO); corrected QT interval (QTc) < ms
Left ventricular ejection fraction (LVEF) < % as determined by multi-gated acquisition scan (MUGA) or echocardiogram (ECHO).
Patients must have normal left ventricular systolic function, as demonstrated by a transthoracic echocardiogram or multi-gated acquisition scan (MUGA) scan showing a normal left ventricular ejection fraction
Cardiac: Left ventricular ejection fraction (LVEF) at rest ? %. For patients aged <  years, shortening fraction (SF) ? % by echocardiogram or Multi Gated Acquisition Scan (MUGA) may be substituted for LVEF.
Left ventricular ejection fraction (LVEF) > % as assessed by echocardiogram or MUGA (multi gated acquisition scan)
Baseline multi-gated acquisition scan (MUGA) or echocardiogram scans with left ventricular ejection fraction (LVEF) of > %.
Left ventricular ejection fraction (LVEF) > % or LV shortening fraction > % by cardiac echocardiogram or by multi-gated acquisition (MUGA) scan
Left ventricular ejection fraction (LVEF) assessment by -dimensional (D) echocardiogram or multi-gated acquisition (MUGA) scan performed within  days prior to registration must be >= %
CELL PROCUREMENT: Subjects must not have left ventricular ejection fraction of < % (shortening fraction < % for pediatric subjects) as measured by echocardiogram or multi-gated acquisition (MUGA)
Left ventricular ejection fraction (LVEF) >= % by multi-gated acquisition scan (MUGA) or rest echocardiogram (ECHO)
Left ventricular ejection fraction (LVEF) <  as determined by multi gated acquisition scan (MUGA) scan or echocardiography (ECHO)
Multi-gated acquisition scan (MUGA) or echocardiogram (ECHO) for left ventricular ejection fraction (LVEF) >= %
Baseline multi-gated acquisition (MUGA) or echocardiogram showing left ventricular ejection fraction (LVEF) >= % within  weeks prior to initiation of neoadjuvant chemotherapy
Left ventricle ejection fraction (LVEF) >= % confirmed by echocardiography (ECHO)/ multi gated acquisition scan (MUGA)
Baseline multi gated acquisition scan (MUGA) or echocardiogram scans with left ventricular ejection fraction (LVEF) of > %
Baseline multi-gated acquisition (MUGA) scan or echocardiogram showing left ventricular ejection fraction (LVEF) >= % at least  weeks prior to initiation of NACT
Left ventricular ejection fraction (LVEF) by echocardiogram (ECHO) or multi gated acquisition scan (MUGA) or magnetic resonance imaging (MRI) >= %
Patients must have normal cardiac function, as evidenced by a left ventricular ejection fraction (LVEF) within institutional normal limits; echocardiogram may be used if multi gated acquisition (MUGA) scan is not available, but the same test must be used throughout the study to evaluate LVEF
Left ventricular ejection fraction (LVEF) >= % by echocardiogram (ECHO) or multi gated acquisition (MUGA) scan
Left ventricular ejection fraction (LVEF) >= % by MUGA (multi gated acquisition) scan or echocardiogram
Left ventricular ejection fraction (LVEF) =< % as documented by multi gated acquisition scan (MUGA) or echocardiogram performed within  days prior to the first study treatment
Patients must obtain a base line echocardiogram or multi gated acquisition scan (MUGA) and require the left ventricular ejection fraction to be within normal limits (or % or higher)
Left ventricular ejection fraction (LVEF) >= % by multi gated acquisition scan (MUGA)/echocardiogram (ECHO)
No active symptomatic ischemic heart disease, myocardial infarction or congestive heart failure within the past year; if multi gated acquisition (MUGA) is obtained, the left ventricular ejection fraction (LVEF) should exceed %
Left ventricular ejection fraction (LVEF) >= % at rest (multi gated acquisition [MUGA] or echocardiogram [ECHO])
Left ventricular ejection fraction (EF) > % by echocardiogram, multi-gated acquisition (MUGA), or cardiac magnetic resonance (MR)
Left ventricular ejection fraction (LVEF) < % as measured by echocardiogram or multi gated acquisition scan (MUGA)
Left ventricular ejection fraction (LVEF) > % as assessed by echocardiogram or multi gated acquisition scan (MUGA)
Left ventricular ejection fraction (LVEF) must be within institutional limits of normal as assessed by echocardiogram (ECHO) or multi gated acquisition scan (MUGA) documented within four weeks prior to first dose of study drug; adequate cardiac reserve ejection fraction (EF) >= %
Left ventricular ejection fraction (LVEF) >= . by multi gated acquisition scan (MUGA) or echocardiogram
Left ventricular ejection fraction (LVEF) =< % as determined by multi gated acquisition (MUGA) scan or echocardiogram (ECHO)
Left ventricular ejection fraction (LVEF) >= % at baseline as determined by either echocardiogram (ECHO) or multi gated acquisition scan (MUGA)
Left ventricular ejection fraction (LVEF) > % (multi gated acquisition scan [MUGA] or echocardiogram) normal per institutional standard
Abnormal echocardiogram (ECHO) or multi-gated acquisition scan (MUGA) at baseline (left ventricular ejection fraction [LVEF] <% and shortening fraction <%). Appropriate correction to be used, if a MUGA is performed.
Left ventricular ejection fraction < % on echocardiogram or multi-gated acquisition (MUGA)
Cardiac ejection fraction >= % by echocardiography or multi gated acquisition (MUGA) (when left ventricular ejection fraction [LVEF] expressed as a range, at least the upper limit should include %)
Baseline multi gated acquisition scan (MUGA) or echocardiogram scans with left ventricular ejection fraction (LVEF) of > %
Left ventricular ejection fraction > % by either multi gated acquisition scan (MUGA) scan or echocardiogram; if ejection fraction (EF) is < %, a cardiology consult should be placed and echocardiogram performed if not already done
Abnormal echocardiogram (ECHO) or multi-gated acquisition scan (MUGA) at baseline (left ventricular ejection fraction [LVEF] < %); appropriate correction to be used if a MUGA is performed
Left ventricular ejection fraction of >= % by multi-gated acquisition (MUGA) scan or echocardiogram
Patients who have abnormal echocardiogram (ECHO) or multi-gated acquisition scan (MUGA) at baseline (left ventricular ejection fraction [LVEF] < %); appropriate correction to be used if a MUGA is performed
Must have an echocardiogram or multi gated acquisition scan (MUGA) indicating left ventricular ejection fraction (LVEF) >= % within  days prior to first dose of study drug
Left ventricular ejection fraction (LVEF) >= %, as determined by radionucleoventilugrams (RVG) (multi-gated acquisition-MUGA) or echocardiogram (ECHO) within  days prior to initiation of protocol therapy
Left ventricular ejection fraction (LVEF) by multi gated acquisition scan (MUGA) or echocardiogram (ECHO) >= %
Left ventricular ejection fraction >= %, as determined by radionuclide ventriculograms (RVG) (multi-gated acquisition scan [MUGA]) or echocardiogram within  days prior to initiation of protocol therapy
Left ventricular ejection fraction estimated by multi gated acquisition scan (MUGA) scan or -dimensional (D)-echocardiogram of at least % cardiology consult is recommended prior to enrollment if a history of coronary artery disease, congestive heart failure (CHF) with estimated left ventricular ejection fraction (LVEF) of < % or clinically significant arrhythmia
Baseline multi gated acquisition scan (MUGA) or echocardiogram (ECHO) must demonstrate left ventricular ejection fraction (LVEF) >= %
Left ventricular ejection fraction (LVEF) >= % at rest (multi gated acquisition [MUGA] or echocardiogram [Echo])
Impaired cardiac function (left ventricular ejection fraction [LVEF] < %) as assessed by echocardiogram (ECHO) or multi gated acquisition (MUGA) scan
Normal cardiac function as demonstrated by a left ventricular ejection fraction >= % on echocardiogram or multi gated acquisition (MUGA) scan
Left ventricular ejection fraction >= % OR shortening fraction of >= % demonstrated on  dimensional (D) echocardiogram or multi gated acquisition scan (MUGA)
Adequate cardiac function (left ventricular ejection fraction [LVEF] >= %) as assessed by echocardiogram (ECHO) or multi gated acquisition scan (MUGA) or other similar cardiac imaging performed within  month of enrollment
Eligible for SCT with left ventricular ejection fraction (LVEF) >= % by multi gated acquisition scan (MUGA) or echocardiogram (ECHO), and diffusing capacity > % predicted by pulmonary function testing
Left ventricular ejection fraction (LVEF) >= % as determined by echocardiogram or multi-gated acquisition scan (MUGA)
LVEF (left ventricular ejection fraction) of % or less as determined by MUGA (multi-gated acquisition) or ECHO (Echocardiogram)
Adequate left ventricular function with ejection fraction >= % by echocardiogram or multi-gated acquisition scan (MUGA) scan
Adequate cardiac function (left ventricular ejection fraction [LVEF] ?% measured by echocardiography or multi-gated acquisition [MUGA] scan)
Normal (greater than %) left ventricular ejection fraction (LVEF) by multi gated acquisition (MUGA) scan or echocardiography
Baseline of Left Ventricular Ejection Fraction (LVEF) ?% measured by echocardiography (ECHO) or multi-gated acquisition scan (MUGA)
Left ventricular ejection fraction (LVEF) >= % by multi gated acquisition (MUGA) scan or echocardiogram (ECHO)
Left ventricular ejection fraction (LVEF) >= %, assessed within  days prior to registration, e.g. by multi gated acquisition (MUGA) scan or echocardiography, or other appropriate diagnostic modality
Left ventricular ejection fraction (LVEF) less than  percent as assessed by echocardiography (or multi-gated acquisition) performed at screening
Baseline multi gated acquisition (MUGA) or echocardiogram (ECHO) must demonstrate left ventricular ejection fraction (LVEF) >= %
Cardiac left ventricular ejection fraction > % by echocardiogram or multi gated acquisition scan (MUGA)
Left ventricular ejection fraction (LVEF) >= % by MUGA (multi gated acquisition) scan or echocardiogram
Left ventricular ejection fraction (LVEF) by echocardiogram or multi gated acquisition scan (MUGA) within institutional normal limits
Subjects should have left ventricular ejection fraction (LVEF) >= % by echocardiogram or multi gated acquisition (MUGA) scan performed within  weeks prior to treatment initiation
Left ventricular ejection fraction must be > % assessed by multi-gated acquisition scan (MUGA) scan or echocardiogram; no myocardial infarction within  months of transplant evaluation
Left ventricular ejection fraction (LVEF) >= % by multi gated acquisition (MUGA) scan or echocardiogram
Patients must have left ventricular ejection fraction (LVEF) > % by multi gated acquisition scan (MUGA) or echocardiogram (ECHO) within  weeks prior to registration
Adequate cardiac function as defined by left ventricular ejection fraction (LVEF) >= % on echocardiogram or multi-gated acquisition scan (MUGA)
Patients must have adequate cardiac function; left ventricular ejection fraction (LVEF) >= % as determined by multi gated acquisition (MUGA) scan or echocardiogram
Abnormal echocardiogram (ECHO) or multi-gated acquisition scan (MUGA) at baseline (left ventricular ejection fraction [LVEF] < %); appropriate correction to be used if a MUGA is performed
